within Pharmacolibrary.Drugs.ATC.D;

model D08AA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.08333333333333333,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Euflavine, also known as ethacridine lactate, is an acridine derivative with antiseptic properties. It has historically been used for topical disinfection, treatment of wounds, and as a urinary antiseptic. Its use has largely fallen out of favor with the advent of modern antibiotics and is rarely used today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies or parameter reports for euflavine in humans or animals could be identified in scientific literature.</p><h4>References</h4><ol><li><p>Zeng, M, et al., &amp; Campochiaro, PA (2017). The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization. <i>Journal of molecular medicine (Berlin, Germany)</i> 95(4) 417â€“429. DOI:<a href=&quot;https://doi.org/10.1007/s00109-016-1498-9&quot;>10.1007/s00109-016-1498-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28004126/&quot;>https://pubmed.ncbi.nlm.nih.gov/28004126</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D08AA03;
